D. Ross Camidge, M.D. Ph.D. Assistant Professor Education: MRC Laboratory of Molecular Biology Cambridge University, Cambridge, UK - 1992 Oxford University Medical School, Oxford, UK – 1995 University of Colorado Denver School of Medicine Division of Medical Oncology Tel: (720) 848-5228 Fax: (720) 848-0360 e-mail: ross.camidge@uchsc.edu

Bio
Dr. Camidge joined the University of Colorado as a visiting professor in November of 2005, and was recruited as full-time faculty from October of 2007.  His focus is in Developmental Therapeutics (Phase I studies) and Thoracic Malignancies.

Research
Dr. Camidge is dual-trained in both medical oncology and clinical pharmacology, with a PhD in molecular biology.  He is the Associate Clinical Director of the Thoracic Oncology Program and an Attending within the Developmental Therapeutics Program.  The Thoracic Oncology Program includes a multi-disciplinary thoracic tumor board, exceptional translational science collaborators, and thoracic medical oncology clinics staffed by four different Attendings. The Developmental Therapeutics Program includes a dedicated pharmacodynamic laboratory, outstanding pharmacokinetic collaborators, and phase I clinical trials clinics staffed by seven different Attendings, each with both general and specific expertise. The Developmental Therapeutics Program acquires access to a very broad range of new drugs and, in conjunction with the comprehensive Thoracic Oncology Program, provides outstanding opportunities to develop new drugs for treating patients with thoracic malignancies and many other cancers. Dr. Camidge is the principal investigator on numerous national and international therapeutic trials.